Published in Pediatrics on September 01, 1963
Mind-Body Health in Uro-Oncology: Research Study | NCT03852030
Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am J Hum Genet (1985) 3.77
Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol (2012) 2.47
Quantitation of gamma-hydroxybutyric acid in dried blood spots: feasibility assessment for newborn screening of succinic semialdehyde dehydrogenase (SSADH) deficiency. Mol Genet Metab (2013) 2.06
The use of the dried blood spot sample in epidemiological studies. J Clin Pathol (1999) 1.95
Newborn screening in North America. J Inherit Metab Dis (2007) 1.93
FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med (2012) 1.85
Newborn screening in the Asia Pacific region. J Inherit Metab Dis (2007) 1.84
Urinary screening tests in the prevention of mental deficiency. Can Med Assoc J (1966) 1.81
Management of inherited metabolic disease. Br Med J (1972) 1.79
Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev (2008) 1.74
Phenylketonuria. Mass screening of newborns in Ireland. Arch Dis Child (1968) 1.72
Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1. J Clin Microbiol (1994) 1.68
Mouse models of human phenylketonuria. Genetics (1993) 1.67
Maternal phenylketonuria: report from the United Kingdom Registry 1978-97. Arch Dis Child (2005) 1.62
Neonatal screening for metabolic and endocrine disorders. Dtsch Arztebl Int (2011) 1.59
Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci U S A (1990) 1.57
Caeruloplasmin isoforms in Wilson's disease in neonates. Arch Dis Child Fetal Neonatal Ed (1998) 1.48
The long quest for neonatal screening for severe combined immunodeficiency. J Allergy Clin Immunol (2012) 1.46
Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans. Genome Res (2012) 1.45
Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene. Am J Hum Genet (1990) 1.45
Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay. J Clin Microbiol (2005) 1.44
Mass screening of the newborn for metabolic disease. Arch Dis Child (1968) 1.43
Commentary on the history and quantitative nature of filter paper used in blood collection devices. Bioanalysis (2012) 1.43
Dietary requirement of phenylalanine in infants with hyperphenylalaninaemia. Arch Dis Child (1973) 1.41
Polymorphic DNA haplotypes at the phenylalanine hydroxylase (PAH) locus in European families with phenylketonuria (PKU). Am J Hum Genet (1989) 1.41
CASE-FINDING IN PHENYLKETONURIA. I. REPORT OF A SURVEY BY THE COLLEGE OF GENERAL PRACTICE OF CANADA. Can Med Assoc J (1964) 1.36
Screening for inherited metabolic disease by plasma chromatography (Scriver) in a large city. Br Med J (1972) 1.32
Evaluation of different cytomegalovirus (CMV) DNA PCR protocols for analysis of dried blood spots from consecutive cases of neonates with congenital CMV infections. J Clin Microbiol (2008) 1.32
NEWBORN PHENYLKETONURIA DETECTION PROGRAM IN MASSACHUSETTS. Am J Public Health Nations Health (1964) 1.31
Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One (2014) 1.29
Hepatitis C virus RNA in dried serum spotted onto filter paper is stable at room temperature. J Clin Microbiol (1998) 1.28
Genetic screening. Epidemiol Rev (2011) 1.27
Diagnosis of phenylketonuria (phenylalanine hydroxylase deficiency, temporary and permanent). Br Med J (1967) 1.27
Polymorphic DNA haplotypes at the phenylalanine hydroxylase (PAH) locus in Asian families with phenylketonuria (PKU). Am J Hum Genet (1989) 1.25
Molecular genetics of phenylketonuria in Orientals: linkage disequilibrium between a termination mutation and haplotype 4 of the phenylalanine hydroxylase gene. Am J Hum Genet (1989) 1.25
Newborn screening for hereditary metabolic disorders in Manitoba, 1965-1970. Can Med Assoc J (1971) 1.17
A prospective community survey for aminoacidaemias. Proc R Soc Med (1968) 1.16
Phenylketonuria. Early detection, diagnosis and treatment. Calif Med (1966) 1.14
Propagating Bacillus subtilis spores in a liquid medium for the Guthrie bioassay. J Clin Microbiol (1980) 1.13
hph-1: a mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis. Genetics (1988) 1.10
Technology of a regional Guthrie test service. J Clin Pathol (1971) 1.08
Pseudomonas aeruginosa antibodies in blood spots from patients with cystic fibrosis. Arch Dis Child (1989) 1.06
Ethical issues with newborn screening in the genomics era. Annu Rev Genomics Hum Genet (2012) 1.06
Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects. Alcohol Res Health (2011) 1.05
Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study. Genet Med (2015) 1.03
The truth of treating patients with phenylketonuria after childhood: the need for a new guideline. J Inherit Metab Dis (2008) 1.03
Neonatal screening for severe combined immunodeficiency. Curr Opin Pediatr (2011) 1.02
High quality genome-wide genotyping from archived dried blood spots without DNA amplification. PLoS One (2013) 1.02
Newborn screening 50 years later: access issues faced by adults with PKU. Genet Med (2013) 1.02
Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis (2007) 1.02
An overview of the clinical use of filter paper in the diagnosis of tropical diseases. Am J Trop Med Hyg (2013) 1.02
Phenylketonuria: old disease, new approach to treatment. Proc Natl Acad Sci U S A (1999) 1.01
Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform. Clin Chim Acta (2013) 1.01
Cotinine and trans 3'-hydroxycotinine in dried blood spots as biomarkers of tobacco exposure and nicotine metabolism. J Expo Sci Environ Epidemiol (2013) 1.01
Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening. J Clin Microbiol (2008) 1.00
Use of dried blood samples for monitoring hepatitis B virus infection. Virol J (2009) 0.99
Detection of markers of hepatitis B infection in serum dried on to filter-paper: an application to field studies. Bull World Health Organ (1982) 0.99
Screening for inherited metabolic disease in Wales using urine-impregnated filter paper. Arch Dis Child (1975) 0.98
Newborn screening. Clin Biochem Rev (2010) 0.98
The introduction of newborn screening for phenylketonuria. A personal history. Eur J Pediatr (1996) 0.96
Phenylketonuria: a 21st century perspective. Nat Rev Endocrinol (2010) 0.96
Care of the adult with phenylketonuria. Eur J Pediatr (1996) 0.96
Newborn Screening for Lysosomal Storage Disorders. J Pediatr Genet (2016) 0.95
Improvement in screening performance and diagnosis of congenital hypothyroidism in Scotland 1979-2003. Arch Dis Child (2006) 0.95
Newborn screening for lysosomal storage disorders in hungary. JIMD Rep (2012) 0.94
Screening for tyrosinaemia type I. Arch Dis Child Fetal Neonatal Ed (1996) 0.94
Characterization of the elemental composition of newborn blood spots using sector-field inductively coupled plasma-mass spectrometry. J Expo Sci Environ Epidemiol (2010) 0.94
Direct and quantitative analysis of underivatized acylcarnitines in serum and whole blood using paper spray mass spectrometry. Anal Bioanal Chem (2012) 0.94
Hemoglobin adducts of benzene oxide in neonatal and adult dried blood spots. Cancer Epidemiol Biomarkers Prev (2008) 0.93
N-Glycan profiling of dried blood spots. Anal Chem (2011) 0.93
Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots. Anal Bioanal Chem (2010) 0.93
Molecular genetics of phenylketonuria and its implications. Am J Hum Genet (1989) 0.93
Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies. Curr Opin HIV AIDS (2015) 0.93
Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism. J Inherit Metab Dis (2008) 0.92
Phenylketonuria and its variations. A review of recent developments. Calif Med (1971) 0.92
Hyperphenylalaninaemia of various types among three-quarters of a million neonates tested in a screening programme. Arch Dis Child (1981) 0.92
Expanded newborn screening in Europe 2007. J Inherit Metab Dis (2007) 0.92
Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. J Inherit Metab Dis (1997) 0.91
Phenylalanine hydroxylase gene mutations in the United States: report from the Maternal PKU Collaborative Study. Am J Hum Genet (1996) 0.91
What we know that could influence future treatment of phenylketonuria. J Inherit Metab Dis (2008) 0.90
Classic phenylketonuria: heterozygote detection during pregnancy. Am J Hum Genet (1973) 0.88
Digital microfluidics: a future technology in the newborn screening laboratory? Semin Perinatol (2010) 0.88
Biochemical characterization of mutant phenylalanine hydroxylase enzymes and correlation with clinical presentation in hyperphenylalaninaemic patients. J Inherit Metab Dis (2008) 0.88
Real-time PCR assay using specimens on filter disks as a template for detection of cytomegalovirus in urine. J Clin Microbiol (2007) 0.88
Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening. J Community Genet (2012) 0.87
Simple, inexpensive, and rapid way to produce Bacillus subtilis spores for the Guthrie bioassay. J Clin Microbiol (1981) 0.87
Optimized DNA extraction from neonatal dried blood spots: application in methylome profiling. BMC Biotechnol (2014) 0.87
Long-term outcome of expanded newborn screening at Boston children's hospital: benefits and challenges in defining true disease. J Inherit Metab Dis (2017) 0.86
Establishment and development of a national newborn screening programme for congenital hypothyroidism in Turkey. J Clin Res Pediatr Endocrinol (2013) 0.86
Simplified procedure for producing Bacillus subtilis spores for the Guthrie phenylketonuria and other microbiological screening tests. J Clin Microbiol (1985) 0.86
Repeated measures of inflammation, blood pressure, and heart rate variability associated with traffic exposures in healthy adults. Environ Health (2015) 0.86
Two years of PKU testing in California. The role of the laboratory. Calif Med (1969) 0.85
Newborn screening for neuropathic lysosomal storage disorders. J Inherit Metab Dis (2010) 0.85
Exploring existing and deliberated community perspectives of newborn screening: informing the development of state and national policy standards in newborn screening and the use of dried blood spots. Aust New Zealand Health Policy (2006) 0.85
Maternal knowledge and attitudes about newborn screening for sickle cell disease and cystic fibrosis. Am J Med Genet A (2009) 0.85
The design and evaluation of a shaped filter collection device to sample and store defined volume dried blood spots from finger pricks. Malar J (2015) 0.85
Newborn screening: new developments, new dilemmas. J Med Ethics (2005) 0.85
Rapid DNA extraction from dried blood spots on filter paper: potential applications in biobanking. Osong Public Health Res Perspect (2014) 0.85
Mini-symposium: newborn screening for inborn errors of metabolism--clinical effectiveness. J Inherit Metab Dis (2006) 0.85
Incorporation of formate-C 14 into the pyrimidine moiety of thiamine. J Bacteriol (1959) 1.72
Sensitivity to analogs of thiamine pyrimidine associated with resistance to amethopterin or purine antagonists. Proc Soc Exp Biol Med (1957) 1.22
A case of pheochromocytoma: diagnosis by the benzodioxane test, urinary hormone studies, and nor-epinephrine assay of the tumor. J Clin Endocrinol Metab (1950) 0.91
ANTAGONISM BETWEEN PURINES IN PURINE-REQUIRING BACILLUS SUBTILIS MUTANTS. Arch Biochem Biophys (1964) 0.83
Studies of a purine- or histidine-requiring mutant of Escherichia coli. J Biol Chem (1955) 0.75
Phenylalanine metabolism: the production of phenylacetaldehyde by a Proteus species. Arch Biochem Biophys (1962) 0.75
Experiments with some mouse tumors and leukemias. Cancer Res (1958) 0.75
Inhibition of tumor growth in mice by a series of 2-substituted thiopyrimidines. Cancer Res (1958) 0.75
Tests for collateral sensitivity or cross resistance in bacterial mutants resistant to amethopterin or purine analogs. Cancer Res (1958) 0.75